January 8, 2018 H3 Biomedicine To Present 2018 Outlook at the 36th Annual J.P. Morgan Healthcare Conference Company highlights focus on driving forward three differentiated, internally generated cancer therapies to clinical proof of concept. Read More
January 2, 2018 H3 Biomedicine to Present at the 36th Annual J.P. Morgan Healthcare Conference Read More